Oppenheimer & Co’s Korro Bio KRRO Stock Holding History

Oppenheimer & Co’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-252	Closed	-$444K	–	1478
2020 Q4	$444K	Hold	252	–	–	0.01%	941
2020 Q3	$242K	Buy	252 +42	+20%	+$45.1K	0.01%	1076
2020 Q2	$244K	Buy	+210	New	+$190K	0.01%	1042

Other funds holding KRRO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oppenheimer & Co's KRRO Position: Q1 2021 in Review

Oppenheimer & Co sold out of Korro Bio (KRRO) in Q1 2021, closing a stake of 252 shares — an estimated $444K sold.

Oppenheimer & Co first reported a position in KRRO in Q2 2020 and held it in 3 quarters. The position peaked at $444K in Q4 2020. 115 funds tracked by Wall St. Rank hold KRRO as of Q1 2021.

Oppenheimer & Co reported no remaining Korro Bio position as of Q1 2021 after selling out during the quarter.
Oppenheimer & Co sold 252 Korro Bio shares in Q1 2021, an estimated $444K.
Oppenheimer & Co first reported a position in Korro Bio in Q2 2020 and held it in 3 quarters.
Oppenheimer & Co's Korro Bio position peaked at $444K in Q4 2020.
115 funds tracked by Wall St. Rank held Korro Bio as of Q1 2021.

Based on Oppenheimer & Co's 13F filing for Q1 2021, filed 10 May 2021.